EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Prestin as a potential biomarker for cochlear injury: Current evidence and future directions

Nienke Streefkerk, Regina Timmer, Alice I E Larsson, Kim E de Jager, Alexander E Hoetink, Wilbert P Vermeij, Alwin D R Huitema, Martine van Grotel, Marry M van den Heuvel-Eibrink

European Archives of Oto-Rhino-Laryngology · 2026-08 · 283 (8) · 4815-4826

DOI: 10.1007/s00405-026-10236-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 05.05.2026. Verfasst von Nienke Streefkerk und 8 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, 3584CS, The Netherlands. n.streefkerk-2@prinsesmaximacentrum.nl. Hauptthemen laut MEDLINE: Sulfate Transporters, Cochlea, Ototoxicity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stichting Kinderen Kankervrij, HORIZON EUROPE Marie Sklodowska-Curie Actions, KWF Kankerbestrijding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sulfate TransportersCochleaOtotoxicityHumansBiomarkersAnimalsAntineoplastic Agents

Stichwörter der Autor:innen

BiomarkerChildhood cancerELISAHearing lossPrestin

Substanzen

BiomarkersSulfate TransportersSLC26A5 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, 3584CS, The Netherlands. n.streefkerk-2@prinsesmaximacentrum.nl.
  • Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht, 3584CS, The Netherlands.
  • Utrecht University, Utrecht, The Netherlands.
  • Oncode Institute, Utrecht, The Netherlands.
  • Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Utrecht-Wilhelmina Children's Hospital, Utrecht, The Netherlands.
  • Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Förderung

  • Stichting Kinderen Kankervrij
  • HORIZON EUROPE Marie Sklodowska-Curie Actions
  • KWF Kankerbestrijding
  • Stichting Prinses Máxima Centrum

Zitieren

APA

Streefkerk, N., Timmer, R., Larsson, A. I. E., de Jager, K. E., Hoetink, A. E., Vermeij, W. P., Huitema, A. D. R., van Grotel, M., & van den Heuvel-Eibrink, M. M. (2026). Prestin as a potential biomarker for cochlear injury: Current evidence and future directions. European Archives of Oto-Rhino-Laryngology, 283(8), 4815-4826. https://doi.org/10.1007/s00405-026-10236-6

Vancouver

Streefkerk N, Timmer R, Larsson AIE, de Jager KE, Hoetink AE, Vermeij WP, et al. Prestin as a potential biomarker for cochlear injury: Current evidence and future directions. European Archives of Oto-Rhino-Laryngology. 2026;283(8):4815-4826. doi:10.1007/s00405-026-10236-6

BibTeX
@article{Streefkerk2026,
  author = {Streefkerk, Nienke and Timmer, Regina and Larsson, Alice I E and de Jager, Kim E and Hoetink, Alexander E and Vermeij, Wilbert P and Huitema, Alwin D R and van Grotel, Martine and van den Heuvel-Eibrink, Marry M},
  title = {Prestin as a potential biomarker for cochlear injury: Current evidence and future directions},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2026},
  volume = {283},
  number = {8},
  pages = {4815--4826},
  doi = {10.1007/s00405-026-10236-6}
}
Kostenlos starten →